CCTV4: 20th China Film Huabiao Awards
BEIJING, April 26, 2025 /PRNewswire/ -- The latest data from the National Film Administration have revealed that the box office revenue of the mainland Chinese film market has already passed the 25 billion yuan (US$3.4 billion) mark in 2025. This...
The New DePin: OKZOO's Environmental AIoT Machine Network Leads New Tech Trend
HO CHI MINH CITY, Vietnam, April 26, 2025 /PRNewswire/ -- The "new DePin" (Decentralized Physical Infrastructure Network) trend is arising, as OKZOO's AIoT devices see explosive growth and traction. AIoT is short for AI combined with Internet of...
Petal Ads Hosts "Think Tank 2025" Seminar in Japan to Empower Japanese Companies' Global Expansion
TOKYO, April 26, 2025 /PRNewswire/ -- Petal Ads, Huawei's leading global mobile advertising platform, today successfully hosted the "Think Tank 2025" seminar in Japan. The event convened prominent brands and domestic agencies from the travel,...
Asia's Premier Poker Festival JOPT 2025 Grand Final: 12 Days of Pure Poker Excitement in Tokyo
TOKYO, April 26, 2025 /PRNewswire/ -- From April 25 to May 6, 2025, the heart of Tokyo's Takadanobaba district will transform into a global poker stage as it hosts the Japan Open Poker Tour 2025 Grand Final. Born in Japan and recognized worldwide,...
Antengene Presents Four Posters at AACR 2025 Highlighting Focuses on AnTenGagerTM TCEs and Synthetic Lethality
SHANGHAI and HONG KONG, April 26, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing...
51Talk Online Education Group Files Annual Report on Form 20-F for Fiscal Year of 2024
SINGAPORE, April 26, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced that it filed its annual report on Form...
Innovent Announces NMPA Approval of Limertinib, a Third-generation EGFR TKI Collaborated with ASK Pharma, for the First-line Treatment of Lung Cancer
SAN FRANCISCO and SUZHOU,China, April 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Concord Medical Files Annual Report on Form 20-F for Fiscal 2024
BEIJING, April 26, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced...